Herbals in pharma industry

25
1/26 HERBALS In Pharmaceutical industry

description

A brief college level seminar for Herbals in pharma industry... Short n Sweet... Regards...Swapnil M. Sanghavi

Transcript of Herbals in pharma industry

Page 1: Herbals in pharma industry

1/26

HERBALSIn

Pharmaceutical industry

Page 2: Herbals in pharma industry

CONTENTS:-• Why we should include herbs in pharmaceuticals?

• Points to be look over precisely before introducing herbs in pharmaceuticals.

• WHO GUIDELINE – Assessment for modern herbal medicines - A brief outline.

• Regulatory status of herbs OR herbal medicines in US & UK.

• Importance of herbs in pharma industries- Asian perspectives.

• Some herbal preparations - Traditional and modern available in market.

/26

2

Page 3: Herbals in pharma industry

Why we should include herbs in pharmaceuticals?

3

Page 4: Herbals in pharma industry

1. HERBS ARE IMPORTANT SOURCE OF LEAD GENERATION:-

DRUG DRUG OF CHOICE IN

ORIGINAL SOURCE

DIGOXIN CCF FLOXGLOVE

COLCHICINE GOUT COLCHICUM SEEDS

QUININE MALARIA CINCHONA

CROMOGLYCATE SODIUM

ASTHMA IN CHILDREN

AMI MAJUS.

4

Page 5: Herbals in pharma industry

2ND REASON:-

Today,We are living in the era of allopathic

but unfortunately not successful so much yet

that we can develop safer new molecules for diseases like cancer, AIDS, diabetes etc.

5

Page 6: Herbals in pharma industry

Plant name/family Drugs Treatment

Cathranthus rosesus L. (Apocynaceae) Vinblastine and vincristine

Hodgkins, Lymphosarcomas and children leukemia.

Podophyllum emodi Wall. (Beriberidaceae)

Podophyllotaxin, Testicular cancer, small cell lung cancer and

lymphomas.

Taxus brevifolius (Taxaceae) Paciltaxel, taxotere Ovarian cancer, lung cancer and malignant

melanoma.

Mappia foetida Miers. Comptothecin, lrenoteccan and

topotecan

Lung, ovarian and cervical cancer.

Comptotheca acuminata Quinoline and comptothecin

alkaloids

used in Japan for the treatment of cervical

cancer

Juniperus communis L. (Cupressaceae) Teniposide and etoposie

Lung cancer

Page 7: Herbals in pharma industry

3rd reason:-Market potential of phytomedicine

Country Years Drugs sales in US $ (billion)

1 Europe Germany France Italy Others

2006 6 3.0 1.6 0.6 0.8

2 Europe 2006 10.0

3 USA 2006 4.0

4 India 2006 1.0

5 Other countries 2006 5.0

6 All countries 2006 30.0 - 60.0

7

Page 8: Herbals in pharma industry

Points to be look over precisely

before introducing

herbs

in

pharmaceuticals.

8

Page 9: Herbals in pharma industry

• standardization of herbs• Procurement from the correct source• Identity of Common Adulterants by

microscopy or other techniques• Quality of the herb • Toxicity studies• Herbal and Drug Interaction

/26

9

Page 10: Herbals in pharma industry

WHO GUIDELINE – Assessment for modern herbal medicines - A brief outline.

Guideline available on following topics:-

•Pharmaceutical assessment•Crude plant material•Plant preparations•Finished product•Stability assessment and shelf life•Activity•Evidence required to support indication

10

Page 11: Herbals in pharma industry

These guidelines describe…

• Quality control of crude drugs material, plant preparations and finished products.

• Stability assessment and shelf life.

• Safety assessment; documentation of safety based on experience or toxicological studies.

• Assessment of efficacy by medical information and biological activity evaluations.

11

Page 12: Herbals in pharma industry

Last amendments in guidelines:-

Following new points are included:-

1.Limits of pesticides

Mainly pesticides like DDT, BHC, toxaphene, and aldrin cause serious side-effects in human beings if the crude drugs are mixed with these agents.

2. Limits of microbial contamination

3. Radioactive contamination

12

Page 13: Herbals in pharma industry

REGULATORY STATUS OF HERBS AND HERBAL PRODUCTS

A LOOPHOLE IN US AND EUROPE GUIDELINE…..???

13

Page 14: Herbals in pharma industry

• Manufacturers have to provide scientific evidence of safety and efficacy of their products.

• In early 60s,• in Europe and US some Asian medicine producers began marketing their

products as nutritional supplements using a legistative loophole which allowed the products with no proven efficacy to be marketed as long as no claims of efficacy on the label.

• For example: Asian medicine producers made claim that St.john’s wart enhances the mood Instead of claiming that st.john’s wart treats dipression.

• By using this loophole in claiming and labeling a new dimension of herbal products that is known as the NUTRACEUTICALS has come out.

• Based on this facts no. of asian producers are enjoying profits by getting marketing authorization of their products in foreign market.

Page 15: Herbals in pharma industry

Importance of herbs in pharma industries

- Asian perspective.

15

Page 16: Herbals in pharma industry

2 major players :-

China and India

Share in global herbal and herbal product market :-

Total global market:- 60 billion US$

India sharing:- only 1% of it

China sharing :- 30 % of it.

16

Page 17: Herbals in pharma industry

Why china is ahead of India in global herbal market?

Reasons:-

1. Most of the Chinese medicines are standardized.

which increase its authenticity in global market.

2. China has created the data base of its encient knowledge of herbs with modern flavor.

17

Page 18: Herbals in pharma industry

CDB example:CNPD-China Natural Products Database

18

Page 19: Herbals in pharma industry

What we (Indian companies) have achieved ?

• No of Indian companies have patented their products in india as well as abroad.

• Examples:

Himalaya Drug Company (HDC), Emami, Aswini, Ayur, Dabur.

19

Page 20: Herbals in pharma industry

HDC patented its ‘Herbal Laxative’ preparation for treatment of constipation in February 2001 in the US.

HDC’s 5 products have been endorsed by more than 250,000 doctors worldwide, and the company exports its products to more than 60 countries.

Today, HDC is the only phytopharmaceutical company whose ayurvedic products are registered as a ‘pharmaceutical specialty’ in Switzerland.

Dabur, which owns 29 patents in the US, is amongst the leaders in healthcare.

It became one of the only two companies in the world to introduce an anti-cancer drug, Intaxel (Paclitaxel).

20

Page 21: Herbals in pharma industry

Some herbal preparations:-traditional preparations:

Asva/Arista - drug is soaked in solution of jaggery and allowed to ferment.

Avaleha/Pak  -  kalka (decoction) of drug is repeatedly boiled and condensed with jaggery

Bhasma - prepared by heating (oxidation) of drug

Churna - a form of powder.

Gutika/vati/Pill - pulverized drug admixed with honey and made up into Gutika or vati or Pill. /26

21

Page 22: Herbals in pharma industry

Modern concept of dosage form:

Tablet (plain or sugar coated or film coated)

lozenges

capsule (hard or soft)

liquid orals (suspension or emulsion or syrup)

external application (cream or ointment)

22

Page 23: Herbals in pharma industry

Available herbal formulation with modern touch:

Mexican Wild Yam 60 Capsules

Beetroot Complex 90 Capsules

Concentrated Cranberry Powder 40G

Ginkgo Plus 90 Capsules

Garlic Plus 30 Capsules

Ginseng 60 Capsules

Milk Thistle Plus Tea

23

Page 24: Herbals in pharma industry

REFERENCES:- 1. Figures as quoted by Asia-Pacific Traditional Medicine and Herbal Technology

Network: APTMNET.COM

2. “India: Herbal Revolution Waiting to Happen,” www.apctt-tm.net, 25 May 2005.

3. US relaxes its guidelines on herbal supplements BMJ 2000;320:208

4. Current status of herbal and their future perspectives R. Perumal Samy, and P. Gopalakrishnakone* Council of Scientific and Industrial

Research, New Delhi

5. WHAT IS INDIAN PHARMA’S NEXT MOVE? iPrexsolutions.com

6. Herbal drug industry ; chaudhary R.D. 8th edition .1999

25